Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cleveland, OH
NPI
1033219340
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (800) 223-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
751 services
Medicare patients, 2024
290
Average age 70
Drug cost, 2024
$375K
857 prescriptions
Company payments, 2025
$6,005
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amir H Hamrahian was code 99214 (office e&m - established), 158 times for 115 patients. In total Amir H Hamrahian billed 751 services in 27 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 158 | 115 | $95.63 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 134 | 102 | $13.19 | $1,767 |
| 99214 Office E&M - Established | Facility | 64 | 53 | $75.92 | $4,859 |
| 99231 Hospital E&M - Subsequent | Facility | 40 | 26 | $40.39 | $1,616 |
| 99204 Office E&M - New | Office | 39 | 39 | $132.46 | $5,166 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 37 | 32 | $13.41 | $496 |
| 99421 Office/Outpatient Services | Office | 34 | 25 | $12.02 | $409 |
| 99213 Office E&M - Established | Office | 27 | 22 | $66.98 | $1,809 |
| 99222 Hospital E&M - Initial | Facility | 22 | 22 | $106.60 | $2,345 |
| 99215 Office E&M - Established | Office | 20 | 17 | $135.34 | $2,707 |
| 99204 Office E&M - New | Facility | 20 | 20 | $95.07 | $1,901 |
| 96372 Injection Administration | Office | 17 | 16 | $11.16 | $190 |
| J0834 Injection, cosyntropin, 0.25 mg | Office | 16 | 15 | $17.76 | $284 |
| 99221 Hospital E&M - Initial | Facility | 16 | 16 | $67.15 | $1,074 |
By year: 2022 $30K for 355 services; 2023 $33K for 386 services; 2024 $46K for 751 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amir H Hamrahian prescribed most often to Medicare patients was Hydrocortisone, with 140 prescriptions and refills. In total Amir H Hamrahian wrote 857 Medicare prescriptions that cost $375K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocortisone Generic | 140 | 281 | 34 | $6,142 |
| Levothyroxine Sodium Generic | 135 | 359 | 36 | $1,560 |
| Amlodipine Besylate Generic | 53 | 131 | 15 | $398 |
| Genotropin Somatropin | 52 | 65 | Under 11 | $96K |
| Dexamethasone Generic | 51 | 51 | 43 | $59.36 |
| Cabergoline Generic | 35 | 85 | Under 11 | $3,182 |
| Testosterone Generic | 32 | 79 | 12 | $6,798 |
| Doxazosin Mesylate Generic | 31 | 77 | Under 11 | $544 |
| Eplerenone Generic | 25 | 51 | Under 11 | $2,133 |
| Fludrocortisone Acetate Generic | 21 | 61 | Under 11 | $397 |
| Prednisone Generic | 19 | 43 | Under 11 | $158 |
| Spironolactone Generic | 15 | 45 | Under 11 | $319 |
| Solu-Cortef Hydrocortisone Sodium Succ/Pf | 14 | 16 | 13 | $610 |
| Lysodren Mitotane | 13 | 13 | Under 11 | $41K |
| Desmopressin Acetate Generic | 12 | 36 | Under 11 | $5,876 |
Brand drugs: 211 claims; generic drugs: 635 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amir H Hamrahian $6,005 ($6,005 in general payments such as food, travel and fees) from 3 companies. The largest payer was Recordati_rare_diseases_inc. with $5,153.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.